Bicycle Therapeutics plc BCYC
$ 14.72
-1.87%
Quarterly report 2024-Q3
added 10-31-2024
Bicycle Therapeutics plc Financial Statements 2011-2024 | BCYC
Annual Financial Statements Bicycle Therapeutics plc
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
802 M | 680 M | 1.22 B | 513 M | 121 M | - | - | - | - | - | - | - | - |
Shares |
35.6 M | 29.7 M | 25.1 M | 19.1 M | 11 M | - | - | - | - | - | - | - | - |
Historical Prices |
22.5 | 22.9 | 48.8 | 26.8 | 10.9 | - | - | - | - | - | - | - | - |
Net Income |
-181 M | -113 M | -66.8 M | -51 M | -30.6 M | -21.8 M | -16.3 M | - | - | - | - | - | - |
Revenue |
27 M | 14.5 M | 11.7 M | 10.4 M | 13.8 M | 7.14 M | 2.06 M | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-190 M | -117 M | -65.6 M | -52 M | -26.3 M | -21.7 M | -16.2 M | - | - | - | - | - | - |
Interest Expense |
3.26 M | 3.34 M | 2.98 M | 457 K | -5.38 M | -665 K | -119 K | - | - | - | - | - | - |
EBITDA |
-183 M | -113 M | -64.2 M | -50.7 M | -25.3 M | -21 M | -15.9 M | - | - | - | - | - | - |
Operating Expenses |
217 M | 131 M | 77.3 M | 62.4 M | 40.1 M | 28.9 M | 18.3 M | - | - | - | - | - | - |
General and Administrative Expenses |
60.4 M | 49.5 M | 32.4 M | 29.2 M | 14.6 M | 8.12 M | 6.41 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Bicycle Therapeutics plc
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
69 M | 52 M | 42.6 M | 42.4 M | 39.6 M | 30.2 M | 30 M | 29.9 M | 29.7 M | 29.6 M | 29.6 M | 29.6 M | 25 M | 24.1 M | 22.1 M | 21.1 M | 19.4 M | 18.1 M | 18 M | 17.9 M | 17.9 M | 7.3 M | 834 K | 503 K | 434 K | 420 K | 397 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-50.8 M | -39.8 M | -26.6 M | - | -49.9 M | -42.6 M | -39.1 M | - | -28.3 M | -26.8 M | -27.6 M | - | -14.7 M | -17.9 M | -16.2 M | -17.4 M | -10.1 M | -12.1 M | -11.3 M | -4.41 M | -9.48 M | -10.2 M | -6.5 M | -6.64 M | -7.69 M | -4.98 M | -2.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
2.68 M | 9.36 M | 19.5 M | - | 5.35 M | 11.4 M | 4.9 M | - | 3.04 M | 4.38 M | 3.86 M | - | 4.33 M | 1.78 M | 1.81 M | 3.85 M | 3.84 M | 1.57 M | 1.13 M | 5.28 M | 614 K | 1.52 M | 6.38 M | 1.06 M | 1.61 M | 1.66 M | 2.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-63.8 M | -46.6 M | -31.7 M | - | -50.8 M | -43.1 M | -41.8 M | - | -29.8 M | -27.3 M | -27.4 M | - | -14.3 M | -17.3 M | -16 M | - | -10.7 M | -12.6 M | -11.6 M | - | -10.3 M | -7.99 M | -3.29 M | - | -6.36 M | -4.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 821 K | - | 814 K | 821 K | 808 K | - | 817 K | 883 K | 818 K | - | 823 K | 819 K | 522 K | - | - | - | - | - | -5.38 M | -2.18 M | -3.19 M | - | -1.36 M | -73 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-61.6 M | -45 M | -30.1 M | - | -49.1 M | -41.5 M | -40.2 M | - | -28.5 M | -26.7 M | -27 M | - | -13.3 M | -17 M | -15.7 M | - | -9.73 M | -12 M | -11.3 M | - | -9.57 M | -7.54 M | -3.08 M | - | -5.83 M | -4.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
66.5 M | 56 M | 51.2 M | - | 56.1 M | 54.5 M | 46.7 M | - | 32.8 M | 31.7 M | 31.2 M | - | 18.6 M | 19.1 M | 17.8 M | 20.9 M | 14.5 M | 14.2 M | 12.8 M | 10 M | 10.9 M | 9.51 M | 9.68 M | 8.6 M | 7.97 M | 6.62 M | 5.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.3 M | 15.9 M | 16.4 M | - | 16.3 M | 14.8 M | 14.5 M | - | 10 M | 11.8 M | 17 M | - | 8.11 M | 7.34 M | 8.14 M | - | 7.15 M | 6.2 M | 5 M | - | 4.79 M | 2.97 M | 3.4 M | - | 2.32 M | 1.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency